The Cooper Companies (COO)
(Delayed Data from NSDQ)
$106.30 USD
-0.50 (-0.47%)
Updated Oct 10, 2024 04:00 PM ET
After-Market: $106.33 +0.03 (0.03%) 5:16 PM ET
2-Buy of 5 2
C Value D Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$106.30 USD
-0.50 (-0.47%)
Updated Oct 10, 2024 04:00 PM ET
After-Market: $106.33 +0.03 (0.03%) 5:16 PM ET
2-Buy of 5 2
C Value D Growth F Momentum F VGM
Zacks News
The Cooper Companies (COO) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
The Cooper Companies (COO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Becton Dickinson (BDX) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Becton Dickinson (BDX) delivered earnings and revenue surprises of 27.27% and 4.65%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
AmerisourceBergen (ABC) Misses Q1 Earnings Estimates
by Zacks Equity Research
AmerisourceBergen (ABC) delivered earnings and revenue surprises of -0.39% and 0.60%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
HSIC vs. COO: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
HSIC vs. COO: Which Stock Is the Better Value Option?
Cooper Companies (COO) Q4 Earnings Lag Estimates, Margins Up
by Zacks Equity Research
Cooper Companies' (COO) fiscal fourth-quarter results reflect solid segmental and geographical performances.
The Cooper Companies (COO) Q4 Earnings Lag Estimates
by Zacks Equity Research
The Cooper Companies (COO) delivered earnings and revenue surprises of -2.67% and 1.52%, respectively, for the quarter ended October 2021. Do the numbers hold clues to what lies ahead for the stock?
Cooper Companies (COO) to Post Q4 Earnings: What's in Store?
by Zacks Equity Research
Cooper Companies' (COO) fiscal fourth-quarter results are likely to reflect segmental strength.
The Cooper Companies (COO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
The Cooper Companies (COO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LH vs. COO: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
LH vs. COO: Which Stock Is the Better Value Option?
Cooper Companies' (COO) Buyout to Boost Women's Healthcare
by Zacks Equity Research
Cooper Companies' (COO) agrees to acquire Generate Life Sciences. It will be an important addition to the former's present offerings, while improving women's healthcare.
LH vs. COO: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
LH vs. COO: Which Stock Is the Better Value Option?
Here's Why You Should Retain Cooper Companies (COO) Stock Now
by Zacks Equity Research
Cooper Companies (COO) continues to benefit from strength in its business segments.
XRAY vs. COO: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
XRAY vs. COO: Which Stock Is the Better Value Option?
HSIC or COO: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
HSIC vs. COO: Which Stock Is the Better Value Option?
The Zacks Analyst Blog Highlights: Alcon, National Vision, The Cooper Companies and EyePoint Pharma
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Alcon, National Vision, The Cooper Companies and EyePoint Pharma
4 Stocks to Keep a Watch on Amid Growing Optical Care Demand
by Riya Anand
Stocks like Alcon (ALC), National Vision (EYE), The Cooper Companies (COO) and EyePoint Pharmaceuticals (EYPT) are gaining momentum amid rising optical care demand.
Cooper Companies (COO) Q3 Earnings & Revenues Beat Estimates
by Zacks Equity Research
Cooper Companies' (COO) fiscal third-quarter earnings reflect solid segmental performance.
The Cooper Companies (COO) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
The Cooper Companies (COO) delivered earnings and revenue surprises of 3.33% and 5.36%, respectively, for the quarter ended July 2021. Do the numbers hold clues to what lies ahead for the stock?
Why The Cooper Companies (COO) Might Surprise This Earnings Season
by Aditi Saraogi
The Cooper Companies (COO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Cooper Companies (COO) to Post Q3 Earnings: What's in Store?
by Zacks Equity Research
Cooper Companies' (COO) fiscal third-quarter results are likely to reflect segmental strength.
The Cooper Companies (COO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
The Cooper Companies (COO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will The Cooper Companies (COO) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
The Cooper Companies (COO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here's Why You Should Retain Cooper Companies (COO) Stock Now
by Zacks Equity Research
Cooper Companies (COO) continues to benefit from strength in its business segments.
Cooper Companies (COO) Unit's MiSight Gets Approval in China
by Zacks Equity Research
CooperVision, a unit of Cooper Companies (COO), receives approval for MiSight 1 day contact lenses from China's National Medical Products Administration for use in China.
Here's Why You Should Retain Abiomed (ABMD) Stock for Now
by Zacks Equity Research
Investors continue to be optimistic about Abiomed (ABMD) owing to its strength in the Impella product line.